Completed PHASE4 INTERVENTIONAL 1-arm NCT01604239

To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis

A 24 Weeks, Multi-centers, Single Arm Phase IV Study to Evaluate the Safety of 'Shinbaro Capsule' Compared With Historical Data of 'Celebrex Capsule' in Patients With Osteoarthritis

Sponsor: Green Cross Corporation

Conditions Osteoarthritis

Interventions Shinbaro Capsule

Updated 7 times since 2017 Last updated: Nov 11, 2013 Started: May 31, 2012 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Osteoarthritis, this trial is completed. The trial is conducted by Green Cross Corporation and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jul 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Green Cross Corporation

Data source: GC Biopharma Corp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bundang, South Korea , Busan, South Korea , Cheongju-si, South Korea , Daegu, South Korea , Deagu, South Korea , Hwasun, South Korea , Ilsan, South Korea , Inchun, South Korea , Jeonju, South Korea , Seoul, South Korea and 2 more locations